Mr. Amit Rajan, Pharma - Expert on USFDA shared his thoughts about the Indian Pharma Sector, what are the challenges industry is facing from USFDA.
Indian players with a larger focus on injectables would continue to face major
challenges in FDA compliance, as the Indian mind-set is not aligned to the
hygiene requirement for sterile manufacturing.
SUBSCRIBE to PhillipCapital India Channel - [ Ссылка ]
Visit [ Ссылка ] to know more about our products & service.
Follow PhillipCapital India:
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
For Disclaimer visit : [ Ссылка ]
